Development of Staccato Prochlorperazine for the treatment of migraine headache.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
75
Inhaled Staccato Placebo
Inhaled Prochlorperazine 5 mg
Inhaled Prochlorperazine10 mg
Arthur H. Elkind, MD
Mount Vernon, New York, United States
Headache Pain Relief at 2 hr Post-dose by 2-point Definition
patient headache pain relief defined as a 2 point reduction as measured on the scale: 0=NO headache pain, 1 = MILD headache pain, 2 = MODERATE headache pain, 3 = SEVERE headache pain
Time frame: 2 hours after treatment
Survival Analysis for Time to Pain Relief
Survival Analysis for Time to the First Success Based on Pain Relief by 2-Point Definition
Time frame: from treatment (time = 0) to 2 hours post treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.